Terri Kelly to retire from Gore after 35 years. Jason Field to serve as President and CEO effective April 1, 2018
Author Archive: AZBio
INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms
Pivotal study aims to evaluate safety and efficacy of company’s novel CBD product candidate in rare type of pediatric epilepsyContinue reading
TGen-led Study Finds Potent Anti-Cancer Drug Effect in Rare Ovarian Cancer
Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months
Doctoral Candidate’s Revolutionary Biosensor Research Earns Top Award
Chi-En Lin, a doctoral candidate in biomedical engineering, has won Metrohm USA’s Young Chemist Award 2018. This is the second year in a row a biomedical engineer from Assistant Professor Jeffrey La Belle’s Lab has won the award.
InnoSTARS 2018: Connect With Chinese Investors And Strategic Partners
THE PATH TO EXPANDING YOUR BUSINESS IN CHINA
Grow Faster By Going Global: Connect With Chinese Investors And Strategic Partners
Cancer Prevention Pharmaceuticals Appoints New AVP of Regulatory Affairs and Quality Assurance
Cancer Prevention Pharmaceuticals, Inc. (CPP), a private clinical stage biotech company developing novel therapeutics to prevent cancer and other diseases, announced today the appointment of Willene Brondum as its new Associate Vice President of Regulatory Affairs and Quality Assurance.Continue reading
TGen offers five great ways to support Rare Disease Day
There are more than 7,000 known rare diseases, affecting more people than cancer and AIDS combined! TGen’s Center for Rare Childhood Disorders gives hope and answers to rare disease patients by using genetic testing to find accurate diagnoses and develop effective treatments – at no cost to the family.Continue reading
Phoenix City Council approves funding for University of Arizona technology medical and life science accelerator
The Phoenix City Council voted unanimously to provide seed funding for a technology medical and life science accelerator at the University of Arizona on the Phoenix Biomedical Campus.
Six Arizona bioscience firms selected for Flinn Foundation entrepreneurship program
Six Arizona bioscience startup firms have been competitively selected by the Flinn Foundation to participate in its 2018 Bioscience Entrepreneurship Program, receiving $30,000 each in funding support and program services administered through a nonprofit partner.Continue reading